Open Access

Therapeutic advances in HFrEF patients who have had a previous worsening HF event

Event: ESC CONGRESS 2020 - The Digital Experience
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session type: Industry Q&A session
Sponsored by Bayer AG
Date: 29 August 2020
Time: 12:45 - 13:45

Session

This content is currently on OPEN ACCESS

Sign in to view the resources

5 presentations in this session

Welcome and introductions.

Speaker: Professor C. Lam (Singapore, SG)
Thumbnail

Stimulating sGC: VICTORIA trial reveals improved outcomes in patients with HFrEF.

Speaker: Professor B. Pieske (Berlin, DE)
Thumbnail

New insights from a deep dive into VICTORIA data and its potential impacts.

Speaker: Professor J. Ezekowitz (Edmonton, CA)
Thumbnail

Putting the VICTORIA trial into perspective with contemporary HFrEF clinical trials.

Speaker: Professor J. Butler (Jackson, US)
Thumbnail

Panel discussion and live Q&A.

Speaker: Professor C. Lam (Singapore, SG)
Speaker: Professor B. Pieske (Berlin, DE)
Speaker: Professor J. Ezekowitz (Edmonton, CA)
Speaker: Professor J. Butler (Jackson, US)
Thumbnail

8 speakers from this session

Professor Carolyn Sp Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)
95 presentations
11 followers

Professor Burkert Pieske

Charite - Campus Virchow-Klinikum (CVK) and German Heart Center, Berlin (Germany)
49 presentations
0 follower

Professor Justin Ezekowitz

University of Alberta, Edmonton (Canada)
2 presentations
0 follower

Professor Javed Butler

University of Mississippi, Jackson (United States of America)
65 presentations
3 followers

Professor Carolyn Sp Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)
95 presentations
11 followers

Professor Burkert Pieske

Charite - Campus Virchow-Klinikum (CVK) and German Heart Center, Berlin (Germany)
49 presentations
0 follower

Professor Justin Ezekowitz

University of Alberta, Edmonton (Canada)
2 presentations
0 follower

Professor Javed Butler

University of Mississippi, Jackson (United States of America)
65 presentations
3 followers

This platform is supported by

logo Novo Nordisk